NexThera Co.
Latest round
- Series B
Last raised
- Sep 2026
Total raised
- $26M
Investors
- 13
About NexThera Co.
, Ltd. operates as a biotechnology company that uses protein-based platform technology to develop a novel therapeutic for thrombocytopenia., Ltd. The company’s technology treats thrombocytopenia, providing clients with an eye drop treatment. The company focuses on developing therapies using recombinant proteins and related technologies. Its research includes improving treatments for age-related macular degeneration, developing production methods for recombinant proteins, and creating antibody-based therapies for thrombocytopenia.
Who invested in NexThera Co.
13 investors across 5 rounds
See all investors in NexThera Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NexThera Co.
Who invested in NexThera Co.?
NexThera Co. has 13 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NexThera Co. raised?
NexThera Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did NexThera Co. last raise money?
NexThera Co.'s most recent round on record is a Series B, in Sep 2026.
What does NexThera Co. do?
NexThera Co. is a biotechnology company.
Where is NexThera Co. headquartered?
NexThera Co. is headquartered in Busan, South Korea.
Which VCs invest in companies like NexThera Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at NexThera Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like NexThera Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.